Janssen to Showcase New Insights and Commitment to Accelerat

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson will showcase data from its neuropsychiatry portfolio at Psych Congress 2023. The...

Related Keywords

United States , American , Reina Benabou , Bill Martin , Janssen Pharmaceutical Companies , Johnson , World Health Organization , Psych Congress , National Council For Mental , National Institute Of Mental Health , Janssen Pharmaceutical Companies Of Johnson , Exchange Commission , Janssen Research Development , Us Census Bureau , National Pregnancy Registry For Atypical Antipsychotics , Janssen Biotech Inc , Companies Of Johnson , None Of Janssen Research , Janssen Pharmaceuticals Inc , American Psychiatric Association , National Alliance On Mental Illness , Janssen Research , Janssen Scientific Affairs , National Pregnancy Registry For Antidepressants , Vice President , Medical Affairs , Risk Evaluation , Mitigation Strategy , Janssen Neuroscience , Global Therapeutic Area Head , Exhibit Hall , Esketamine Nasal Spray Dosed , Adults With Treatment Resistant Depression , Subgroup Analysis , Term Efficacy , Term Safety , Esketamine Nasal Spray , Treatment Resistant Depression , Final Results , World Safety Profile , Esketamine Nasal Spray During , After Approval , Work Productivity Loss , Treatment Resistant Depression Treated , Adverse Events , Interest Occurring With Esketamine Nasal Spray , Quetiapine Extended Release , Nasal Spray Improves Functioning , Results From , Randomized Phase , Health Plan Prior Authorization Criteria , Paliperidone Palmitate , Month Formulation , Year Analysis , Adults With Schizophrenia , Safety Outcomes When Transitioning , Month Versus Paliperidone Palmitate , Adult Patients , Open Label Extension Study Compared , Real World Data , Month Formulations , Insomnia Disorder , Anhedonia Severity , Major Depressive Disorder , Patient Perspective , Anhedonia Symptoms , National Council , Mental Wellbeing , National Pregnancy Registry , Prescribing Information , Medication Guide , Patient Information , Neuroleptic Malignant Syndrome , Lewy Body , Malignant Syndrome , Pharmaceutical Companies , Infectious Diseases , Janssen Biotech , Private Securities Litigation Reform Act , Annual Report , Note Regarding Forward Looking , Quarterly Reports , Depressive Disorder , National Institute , Mental Health , National Alliance , Mental Illness , American Psychiatric , Practice Guideline , New Practice Guideline , Accessed August , Janssen Pharmaceuticals , Janssen Pharmaceutical Companies Of Johnson Amp , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,